A Phase II Study of Bipolar Androgen-based Therapy for Men With Androgen Ablation Naive Recurrent Prostate Cancer

Trial Profile

A Phase II Study of Bipolar Androgen-based Therapy for Men With Androgen Ablation Naive Recurrent Prostate Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Dec 2016

At a glance

  • Drugs Testosterone cipionate (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Acronyms BAT
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 24 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Dec 2014 Planned End Date changed from 1 Jan 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top